Double Medical Technology Inc. (002901.SZ) forecasts a net profit of 350 million to 390 million yuan for the year 2024, an increase of 493.50% to 561.33%.

Double Medical Technology Inc. (002901.SZ) released its performance forecast for the year 2024, expecting a net profit attributable to shareholders of the listed company of 3.5 billion to 3.9 billion yuan, a year-on-year growth of 493.50% to 561.33%. The announcement stated that as the orthopedic consumables centralized procurement policy is gradually implemented, the company actively adjusts its business strategy, and the orthopedic business line is gradually stabilizing and recovering. During the reporting period, the company continued to vigorously expand its non-orthopedic consumables business categories, achieving good growth in minimally invasive surgery, dental, neurosurgery, and other product lines.